Deep Track Capital, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Deep Track Capital, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,149,305
-11.2%
2,086,7040.0%0.08%
-25.9%
Q2 2023$2,420,577
-50.4%
2,086,704
-35.5%
0.11%
-44.3%
Q1 2023$4,884,430
-69.9%
3,234,722
-50.2%
0.20%
-70.5%
Q4 2022$16,242,440
-55.0%
6,496,976
-24.0%
0.68%
-58.7%
Q3 2022$36,074,0008,548,3871.65%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders